Allspring Global Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Allspring Global Investments's EW Position: Q2 2026 in Review
Allspring Global Investments increased its Edwards Lifesciences (EW) stake by 21% in Q2 2026, buying an estimated $35.9M and bringing the position to 2,489,396 shares worth $229M. The position accounts for 0.35% of the portfolio, ranked #61.
Allspring Global Investments first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $344M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Allspring Global Investments held 2,489,396 shares of Edwards Lifesciences worth $229M as of Q2 2026.
- Allspring Global Investments bought 428,505 Edwards Lifesciences shares in Q2 2026, an estimated $35.9M.
- Edwards Lifesciences made up 0.35% of Allspring Global Investments's portfolio in Q2 2026, its #61 holding.
- Allspring Global Investments first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
- Allspring Global Investments's Edwards Lifesciences position peaked at $344M in Q4 2021.
- 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.